ConductScience.org, home

Paper38274635

COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign.

Mead MN and 6 others. Cureus, 2024. Cited by 4 papers, by iCite. Retracted.

Cite this record

ConductScience Library. COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign. Papers, record 38274635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38274635

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign.
PubMed
Journal
Cureus
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Retracted Publication
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.52, provisional
iCite
Retracted
Yes, by PubMed's record
PubMed
Revised in PubMed
2024-10-23
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mead MNM Nathaniel
2Seneff SStephanie
3Wolfinger RRuss
4Rose JJessica
5Denhaerynck KKris
6Kirsch SSteve
7McCullough PAPeter A

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Retracted by38414517Retraction: COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign.https://conductscience.org/library/papers/38414517

Source PubMed

Download CSV of comments and corrections

References214

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133899038COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the room.Lancet Microbe2021https://conductscience.org/library/papers/33899038PubMed
234400651Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action.NPJ Vaccines2021https://conductscience.org/library/papers/34400651PubMed
336266115A Systematic Review and Meta-analysis of the Association Between SARS-CoV-2 Vaccination and Myocarditis or Pericarditis.Am J Prev Med2023https://conductscience.org/library/papers/36266115PubMed
437634619Association between virus variants, vaccination, previous infections, and post-COVID-19 risk.Int J Infect Dis2023https://conductscience.org/library/papers/37634619PubMed
515258090Emergent human pathogen simian virus 40 and its role in cancer.Clin Microbiol Rev2004https://conductscience.org/library/papers/15258090PubMed
636041291Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.J Autoimmun2022https://conductscience.org/library/papers/36041291PubMed
735475680Repeated vaccination and 'vaccine exhaustion': relevance to the COVID-19 crisis.Expert Rev Vaccines2022https://conductscience.org/library/papers/35475680PubMed
833741972Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection.Nat Commun2021https://conductscience.org/library/papers/33741972PubMed
933892403Long COVID: An overview.Diabetes Metab Syndr2021https://conductscience.org/library/papers/33892403PubMed
1035436552Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs.Food Chem Toxicol2022https://conductscience.org/library/papers/35436552PubMed
1125263094The ReNAissanCe of mRNA-based cancer therapy.Expert Rev Vaccines2015https://conductscience.org/library/papers/25263094PubMed
1237192595COVID-19, post-acute COVID-19 syndrome (PACS, "long COVID") and post-COVID-19 vaccination syndrome (PCVS, "post-COVIDvac-syndrome"): Similarities and differences.Pathol Res Pract2023https://conductscience.org/library/papers/37192595PubMed
1333727699Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group.Nat Med2021https://conductscience.org/library/papers/33727699PubMed
1437939032Risk of Coronavirus Disease 2019 (COVID-19) among those up-to-date and not up-to-date on COVID-19 vaccination by US CDC criteria.PLoS One2023https://conductscience.org/library/papers/37939032PubMed
1537243095IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein.Vaccines (Basel)2023https://conductscience.org/library/papers/37243095PubMed
1635076665Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.JAMA2022https://conductscience.org/library/papers/35076665PubMed
1736212794Viruses, vaccines and cardiovascular effects.Br J Cardiol2022https://conductscience.org/library/papers/36212794PubMed
1835603211Adaptive Immune Responses and Immunity to SARS-CoV-2.Front Immunol2022https://conductscience.org/library/papers/35603211PubMed
1936910517Emergence of Post COVID-19 Vaccine Autoimmune Diseases: A Single Center Study.Infect Drug Resist2023https://conductscience.org/library/papers/36910517PubMed
2037951793COVID-19 vaccination attitudes, values, intentions: US parents for their children, September 2021.Vaccine2023https://conductscience.org/library/papers/37951793PubMed

See all 214 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41495048Breaking barriers in prostate cancer: the mRNA vaccine breakthrough and what comes next.NPJ Vaccines2026https://conductscience.org/library/papers/41495048PubMed
38932320COVID-19 Vaccination Reporting and Adverse Event Analysis in Taiwan.Vaccines (Basel)2024https://conductscience.org/library/papers/38932320PubMed
38655863
Reply to Letter to the Editor: 'Cardiovascular Events After Coronavirus Disease 2019 Vaccinations: Hypersensitivity Myocarditis After Coronavirus Disease 2019 Vaccines, Diagnostic and Long-term Considerations'.
Anatol J Cardiol2024https://conductscience.org/library/papers/38655863PubMed
38558730Myocarditis, Coagulopathy, and Small Fibre, Sensory, and Multiple Cranial Nerve Neuropathy Complicating BNT162b2 Vaccination: A Case Report.Cureus2024https://conductscience.org/library/papers/38558730PubMed

Download CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38274635

GET https://conductscience.org/api/papers/v1/38274635/references?page=2